London, UK – IntelligenceQ, a startup founded by Swapnil Khadke and Neil Robertson, has received its first venture investment from Plug and Play Tech Center, an American venture capital firm headquartered in California. Plug and Play has backed over 30 unicorns and focuses on early-stage technology companies.

This investment will support the continued development of IntelligenceQ’s AI platform, GyaniMed™, and opens the door to commercial opportunities and partnerships in the United States.

GyaniMed™ is designed to help pharmaceutical and biotech teams manage quality, regulatory, and manufacturing data more effectively. It brings structure and traceability to fragmented lab and compliance data, using AI to improve decision-making and reduce manual effort across the development lifecycle.

Following this raise, IntelligenceQ has opened a larger £1.5–2m seed round to support team expansion, product development, and go-to-market efforts across regulated pharmaceutical markets.

“This is a major milestone for us after two years of bootstrapping and reaching TRL 5 with our first proof of concept,” said Dr. Swapnil Khadke, co-founder and CEO of IntelligenceQ. “Plug and Play’s support gives us the momentum and network to grow responsibly. We’re focused on building a dependable product that genuinely helps pharmaceutical teams navigate complex regulatory environments — backed by our work with CPI and our first patent filing.”